BETHESDA, Md. (PRWEB) June 20, 2018 -- Mytonomy, a leader in patient engagement, education and experience cloud solutions and an advocate for people living with diabetes, today announced the company’s participation at the upcoming American Diabetes Association (ADA) 78th Scientific Sessions and DiabetesMine D-Data ExChange being held in Orlando, Florida. Applying principles of microlearning and behavioral sciences, Mytonomy combines cloud-based software, called the Patient Experience Cloud™, with cinematic quality video content and a powerful analytic engine to engage and empower people with diabetes and their care teams, leading to better clinical and financial outcomes.
On June 25 at the ADA meeting, Magdalena Bogun, MD, Endocrinologist at the Naomi Berrie Diabetes Center, New York-Presbyterian/Columbia University Medical Center (Columbia), will present an oral abstract on the results of an IRB approved, prospective, non-randomized, multi-site pilot study to assess the efficacy of delivering Mytonomy’s video-based microlearning content to people living with diabetes who had recently been started on insulin therapy. MedStar Diabetes Institute (MedStar) and Duke Health also participated in the study.
Dr. Bogun will present outcomes related to the effect of online video-based microlearning education on patient activation and attitudes towards diabetes self-management and insulin use. Fellow Principal Investigators, Nicole Jelesoff, MD, Clinical Endocrinologist, Division of Endocrinology Metabolism and Nutrition, Duke University Medical Center and Michelle Magee, MD, Director, MedStar Diabetes Institute and an Associate Professor of Medicine of the Georgetown University School of Medicine, will also be on hand along with Sanofi and Mytonomy clinical leadership and executives. Details are as follows:
Title: Innovative Tailored Microlearning Approach to Insulin Self-management Education Shows High Engagement Levels Among Diverse Adults
Location: Orange County Convention Center, W204, Orlando, FL
Venue: ADA 78th Scientific Sessions
Session: Diabetes Self-Management Education and Support - Embracing Data and Digital Dialogue Advances (8:00 AM - 10:00 AM)
Date: June 25, 2018
Time: 8:45 am Eastern Time
Additional Co-Authors include: Connie R. Thacker, BA, BA, CCRP, Associate in Research, Clinical Research Director, Division of Endocrinology Metabolism and Nutrition, Duke University Medical Center; Carine M. Nassar, Program Director, MedStar Diabetes Institute; Johanna Camacho Rivera, Adult Nurse Practitioner, Columbia; Clayton J. Bourges, III, Clinical Research Coordinator, Medstar Diabetes Institute; Karan Sethi, Research Assistant, Duke Health; Lisa Egbuonu-Davis, MD, MPH, MBA, Global Patient Centered Outcomes and Solutions, Sanofi; Anne C. Beal, MD, MPH, Global Head Patient Solutions, Sanofi; Deborah A. Greenwood, Ph.D, RN, CDE, Chief Digital Research Officer, Diabetes, Mytonomy; Herlene Chatha, MD, Medical Director, Mytonomy; Anjali Kataria, CEO, Mytonomy; Diana B. McNeill, MD, FACP, Professor of Medicine, Director of Duke HEAD, Duke University Medical Center; Robin Goland, MD, Co-Director of the Naomi Berrie Diabetes Center, J. Merrill Eastman Professor of Clinical Diabetes, New York-Presbyterian/Columbia University Medical Center.
Additionally, Mytonomy’s Chief Digital Research Officer for Diabetes, Deborah Greenwood, will be presenting and demonstrating Mytonomy’s Patient Experience Cloud platform at the DiabetesMine D-Data ExChange on June 22, 2018. Greenwood will show how Mytonomy’s solution can extend the reach of diabetes self-management education and support services by creating a “Virtual CDE® (Certified Diabetes Educator®) in Your Living-room Program to assist patients in remaining connected to their health systems and the valuable instruction, without adding additional burden to hospital and clinic staff.
Title: Virtual CDE in Your Living-Room
Location: Crowne Plaza Universal, Orlando, FL
Venue: DiabetesMine D-Data ExChange
Date: June 22, 2018
“At Mytonomy, we are passionate about making lives better for people with diabetes and their families. We are honored to participate in these venues and grateful to our clinical sponsors at leading health systems to help advance and test new digital solutions like ours. We are enthusiastic to play a role in transforming the diabetes patient experience,” said Kataria. “Mytonomy is part of a new wave of digital health companies using technology, data and science to improve experiences of patients, caregivers, and care teams simultaneously, with the effect of improving clinical outcomes and financial performance for all.”
About Mytonomy
Mytonomy is the leader in patient experience cloud solutions that leverage microlearning and behavioral science to drive better health outcomes, lower costs and increase top line growth. By applying cognitive learning principles to healthcare, Mytonomy promotes longitudinal patient activation and engagement through its Patient Experience Cloud® software platform that can be accessed from any device, anywhere, at any time. Mytonomy delivers data-driven, personalized information at scale across the care continuum improving staff and patient experience. Mytonomy is a venture-backed, enterprise software and award-winning content production company. The founders are former executives from Google, Oracle, FDA and The Advisory Board Company. Visit http://www.mytonomy.com for more information.
Mike MIniati, Mytonomy, Inc., http://www.mytonomy.com, +1 8137776552, [email protected]
SOURCE Mytonomy, Inc.
Share this article